Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 47.62 % in the past year, substantial increase in net sales/revenue by 38.8 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 1080 %. Marginal increase in other income during this quarter, up by 110.71%.
- Profit over the Year and quarter: Significant improvement in profitability for MEDICO REMEDIES LIMITED. Notable increase of 75.48 % in net profit Year to Year, MEDICO REMEDIES LIMITED’s profitability increased by 114.46 % in this quarter.
- EPS over the Year and quarter: EPS increased by 76.19 % Year to Year. EPS increased by 117.65 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 27.992 Cr | Rs. 29.772 Cr | Rs. 41.323 Cr | + 38.8 % | + 47.62 % |
| Expenses | Rs. 24.83 Cr | Rs. 27.04 Cr | Rs. 36.67 Cr | + 35.61 % | + 47.68 % |
| Operating Profit | Rs. 3.16 Cr | Rs. 2.73 Cr | Rs. 4.65 Cr | + 70.33 % | + 47.15 % |
| OPM % | 11.29 % | 9.17 % | 11.25 % | + 2.08 % | -0.04 % |
| Other Income | Rs. 0.05 Cr | Rs. 0.28 Cr | Rs. 0.59 Cr | + 110.71 % | + 1080 % |
| Interest | Rs. 0.21 Cr | Rs. 0.22 Cr | Rs. 0.25 Cr | + 13.64 % | + 19.05 % |
| Depreciation | Rs. 0.73 Cr | Rs. 0.72 Cr | Rs. 0.74 Cr | + 2.78 % | + 1.37 % |
| Profit before tax | Rs. 2.27 Cr | Rs. 2.07 Cr | Rs. 4.25 Cr | + 105.31 % | + 87.22 % |
| Tax % | 22.31 % | 29.96 % | 27 % | -2.96 % | + 4.69 % |
| Net Profit | Rs. 1.77 Cr | Rs. 1.45 Cr | Rs. 3.1 Cr | + 113.79 % | + 75.14 % |
| EPS in Rs | Rs. 0.21 | Rs. 0.17 | Rs. 0.37 | + 117.65 % | + 76.19 % |
Today, we’re looking at MEDICO REMEDIES LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 47.62 %. However, it did see a marginal increase of 38.8 % from the previous quarter. Expenses ticked up slightly by 35.61 % quarter-on-quarter, aligning with the annual rise of 47.68 %. Operating profit, while up 47.15 % compared to last year, faced a quarter-on-quarter increase of 70.33 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.04 %, but an expansion of 2.08 % sequentially. Other income rose by 110.71 % compared to the last quarter, despite an annual growth of 1080 %. Interest expenses surged remarkably by 13.64 % from the previous quarter, yet the year-over-year increase remains at a moderate 19.05 %. Depreciation costs climbed by 2.78 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 1.37 %. Profit before tax grew annually by 87.22 % but saw an increase from the preceding quarter by 105.31 %.
Tax expenses as a percentage of profits increased slightly by 4.69 % compared to last year, with a more notable quarter-on-quarter decrease of -2.96 %. Net profit rose by 75.14 % year-on-year but experienced a 113.79 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 76.19 % but a quarterly rise of 117.65 %. In summary, MEDICO REMEDIES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 27.992 Cr | Rs. 29.772 Cr | Rs. 41.323 Cr | + 38.8 % | + 47.62 % |
| Expenses | Rs. 24.83 Cr | Rs. 27.04 Cr | Rs. 36.67 Cr | + 35.61 % | + 47.68 % |
| Operating Profit | Rs. 3.16 Cr | Rs. 2.73 Cr | Rs. 4.65 Cr | + 70.33 % | + 47.15 % |
| Net Profit | Rs. 1.77 Cr | Rs. 1.45 Cr | Rs. 3.1 Cr | + 113.79 % | + 75.14 % |
| EPS in Rs | Rs. 0.21 | Rs. 0.17 | Rs. 0.37 | + 117.65 % | + 76.19 % |
In reviewing MEDICO REMEDIES LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 47.62 % year-on-year growth, however, there was a minor increase of 38.8 % from the previous quarter. Expenses rose by 47.68 % compared to the previous year, with a 35.61 % increase quarter-on-quarter. Operating Profit surged by 47.15 % annually, and saw a 70.33 % increase from the last quarter.
Net Profit showed yearly increase of 75.14 %, and experienced a 113.79 % increase from the previous quarter. Earnings Per Share (EPS) rose by 76.19 % annually, however rose by 117.65 % compared to the last quarter. In essence, while MEDICO REMEDIES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
